[SCHEDULE 13G] Omada Health, Inc. SEC Filing

Rhea-AI Filing Summary

Omada Health, Inc. Schedule 13G shows that a set of related reporting persons (U.S. Venture Partners X, L.P.; USVP X Affiliates, L.P.; Presidio Management Group X, L.L.C.; and Casey M. Tansey) report collective beneficial ownership of the company's common stock. The filings report 4,571,769 shares held directly by USVP X and an additional 146,257 shares held by USVP X Affiliates, for a combined reported position of 4,718,026 shares. The filing states this represents approximately 8.2% of the outstanding common stock based on 57,574,921 shares of common stock outstanding used for the calculation. The reporting persons disclaim group status and clarify that Presidio Management Group X, L.L.C. acts as general partner and certain named individuals may be deemed to share voting and dispositive power, while each disclaims beneficial ownership except to the extent of any pecuniary interest.

Insights

Financial Analyst

TL;DR: A venture investor group holds a meaningful minority stake (~8.2%), disclosed without intent to influence control.

The Schedule 13G reveals that USVP-linked funds collectively hold 4,718,026 shares of Omada Health common stock, about 8.2% of the class on the outstanding-share base cited. For investors this is a non-controlling but material passive stake typical of institutional venture investors. The statement expressly disclaims group status and indicates the holdings are not intended to change or influence control. The filing clarifies allocation between USVP X (4,571,769 shares) and USVP X Affiliates (146,257 shares) and identifies Presidio Management Group X as general partner potentially exercising shared voting/dispositive power while individuals disclaim direct beneficial ownership except for pecuniary interest.

Corporate Governance Expert

TL;DR: Ownership structure is transparent; reporting persons stress passive intent and disclaim a formal group.

The disclosure provides governance-relevant detail: a single management entity (Presidio Management Group X) is the general partner for the reporting funds and certain named members may be deemed to share authority over the reported securities. Importantly, the filing uses Schedule 13G and includes a certification that the position is not held to influence control, indicating a passive investor posture rather than an activist or control-seeking intent. This reduces immediate governance risk associated with a contested change in control, though the size of the stake is sufficient to matter in close votes.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Omada Health, Inc.

(Name of Issuer)

Common Stock, par value $0.001 per share

(Title of Class of Securities)

68170A108

(CUSIP Number)

06/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 68170A108

1

Names of Reporting Persons

U.S. Venture Partners X, L.P.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 4,571,769.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 4,571,769.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

4,571,769.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

7.9 %

12

Type of Reporting Person (See Instructions)

PN

Comment for Type of Reporting Person: The reported securities are owned directly by U.S. Venture Partners X, L.P. (USVP X). Presidio Management Group X, L.L.C. (PMG X) is the general partner of each of the USVP X Funds (as defined below) and may be deemed to have sole voting and dispositive power over the reported securities held by the USVP X Funds. Dr. Jonathan Root, a member of the Issuer's board of directors, Irwin Federman, Steven Krausz and Richard Lewis are the managing members of PMG X, who may be deemed to share voting and dispositive power over the shares held by the USVP X Funds. In addition, Casey M. Tansey is the managing partner of PMG X and may be deemed to share voting and dispositive power over the reported securities held by the USVP X Funds. Each such persons and entities disclaim beneficial ownership of the reported securities held by the USVP X Funds, except to the extent of any pecuniary interest therein. The amount beneficially owned by each Reporting Person is determined based on 57,574,921 shares of Common Stock outstanding as of August 5, 2025 as reported by the Issuer in its Quarterly Report on Form 10-Q, filed with the Securities and Exchange Commission (the Commission) on August 8, 2025 (the Form 10-Q).

SCHEDULE 13G

CUSIP No. 68170A108

1

Names of Reporting Persons

USVP X Affiliates, L.P.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 146,257.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 146,257.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

146,257.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0.3 %

12

Type of Reporting Person (See Instructions)

PN

Comment for Type of Reporting Person: Consists of (i) 4,571,769 shares of Common Stock held directly by USVP X, and (ii) 146,257 shares of Common Stock held directly by USVP X Affiliates. PMG X is the general partner of each of the USVP X Funds and may be deemed to have sole voting and dispositive power over the reported securities held by the USVP X Funds. Dr. Jonathan Root, a member of the Issuer's board of directors, Irwin Federman, Steven Krausz and Richard Lewis are the managing members of PMG X, who may be deemed to share voting and dispositive power over the shares held by the USVP X Funds. In addition, Casey M. Tansey is the managing partner of PMG X and may be deemed to share voting and dispositive power over the reported securities held by the USVP X Funds. Each such persons and entities disclaim beneficial ownership of the reported securities held by the USVP X Funds, except to the extent of any pecuniary interest therein. The amount beneficially owned by each Reporting Person is determined based on 57,574,921 shares of Common Stock outstanding as of August 5, 2025 as reported by the Issuer in its Form 10-Q.

SCHEDULE 13G

CUSIP No. 68170A108

1

Names of Reporting Persons

Presidio Management Group X, L.L.C.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 4,718,026.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 4,718,026.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

4,718,026.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

8.2 %

12

Type of Reporting Person (See Instructions)

OO

Comment for Type of Reporting Person: Consists of (i) 4,571,769 shares of Common Stock held directly by USVP X, and (ii) 146,257 shares of Common Stock held directly by USVP X Affiliates. PMG X is the general partner of each of the USVP X Funds and may be deemed to have sole voting and dispositive power over the reported securities held by the USVP X Funds. Dr. Jonathan Root, a member of the Issuer's board of directors, Irwin Federman, Steven Krausz and Richard Lewis are the managing members of PMG X, who may be deemed to share voting and dispositive power over the shares held by the USVP X Funds. In addition, Casey M. Tansey is the managing partner of PMG X and may be deemed to share voting and dispositive power over the reported securities held by the USVP X Funds. Each such persons and entities disclaim beneficial ownership of the reported securities held by the USVP X Funds, except to the extent of any pecuniary interest therein. The amount beneficially owned by each Reporting Person is determined based on 57,574,921 shares of Common Stock outstanding as of August 5, 2025 as reported by the Issuer in its Form 10-Q.

SCHEDULE 13G

CUSIP No. 68170A108

1

Names of Reporting Persons

Casey M Tansey

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 4,718,026.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 4,718,026.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

4,718,026.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

8.2 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: Consists of (i) 4,571,769 shares of Common Stock held directly by USVP X, and (ii) 146,257 shares of Common Stock held directly by USVP X Affiliates. PMG X is the general partner of each of the USVP X Funds and may be deemed to have sole voting and dispositive power over the reported securities held by the USVP X Funds. Dr. Jonathan Root, a member of the Issuer's board of directors, Irwin Federman, Steven Krausz and Richard Lewis are the managing members of PMG X, who may be deemed to share voting and dispositive power over the shares held by the USVP X Funds. In addition, Casey M. Tansey is the managing partner of PMG X and may be deemed to share voting and dispositive power over the reported securities held by the USVP X Funds. Each such persons and entities disclaim beneficial ownership of the reported securities held by the USVP X Funds, except to the extent of any pecuniary interest therein. The amount beneficially owned by each Reporting Person is determined based on 57,574,921 shares of Common Stock outstanding as of August 5, 2025 as reported by the Issuer in its Form 10-Q.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Omada Health, Inc.
(b)	Address of issuer's principal executive offices: 611 Gateway Blvd, Suite 120, South San Francisco, CA 94080
Item 2.
(a)	Name of person filing: This Schedule 13G is being filed on behalf of (i) U.S. Venture Partners X, L.P., a Delaware limited partnership, (ii) USVP X Affiliates, L.P., a Delaware limited partnership, (iii) Presidio Management Group X, L.L.C., a Delaware limited liability company and (iv) Casey M. Tansey, a citizen of the United States (the foregoing entities and individuals are collectively referred to as the Reporting Persons). The Reporting Persons expressly disclaim status as a "group" for purposes of this Schedule 13G. The agreement among the Reporting Persons to file jointly in accordance with the provisions of Rule 13d-1(k)(1) under the Act is attached to this Statement as Exhibit 1. Other than those securities reported herein as being held directly by such Reporting Person, each Reporting Person disclaims beneficial ownership of all securities reported in this Statement except to the extent of such Reporting Person's pecuniary interest therein.
(b)	Address or principal business office or, if none, residence: The principal business office of the Reporting Persons is 1460 El Camino Real, Suite 100, Menlo Park, California 94025.
(c)	Citizenship: See Item 2(a)
(d)	Title of class of securities: Common Stock, par value $0.001 per share
(e)	CUSIP No.: 68170A108
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: See Row 9 of the cover page for each Reporting Person and the corresponding comments.
(b)	Percent of class: See Row 11 of the cover page for each Reporting Person and the corresponding comments.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: See Row 5 of the cover page for each Reporting Person and the corresponding comments.
	(ii) Shared power to vote or to direct the vote: See Row 6 of the cover page for each Reporting Person and the corresponding comments.
	(iii) Sole power to dispose or to direct the disposition of: See Row 7 of the cover page for each Reporting Person and the corresponding comments.
	(iv) Shared power to dispose or to direct the disposition of: See Row 8 of the cover page for each Reporting Person and the corresponding comments.
Item 5.	Ownership of 5 Percent or Less of a Class.
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

U.S. Venture Partners X, L.P.

Signature:	/s/ Dale Holladay
Name/Title:	Dale Holladay, Authorized Signatory
Date:	08/14/2025

USVP X Affiliates, L.P.

Signature:	/s/ Dale Holladay
Name/Title:	Dale Holladay, Authorized Signatory
Date:	08/14/2025

Presidio Management Group X, L.L.C.

Signature:	/s/ Dale Holladay
Name/Title:	Dale Holladay, Authorized Signatory
Date:	08/14/2025

Casey M Tansey

Signature:	/s/ Dale Holladay, Attorney-in-Fact for Casey M. Tansey
Name/Title:	Dale Holladay, Attorney-in-Fact
Date:	08/14/2025